Suncoast Equity Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.8M Sell
38,951
-3,760
-9% -$3.81M 4.3% 9
2025
Q4
$45.9M Sell
42,711
-536
-1% -$513K 4.64% 8
2025
Q3
$33M Sell
43,247
-236
-0.5% -$176K 3.29% 13
2025
Q2
$33.9M Buy
43,483
+84
+0.2% +$65.3K 3.47% 14
2025
Q1
$35.8M Buy
43,399
+1,620
+4% +$1.35M 4.05% 12
2024
Q4
$32.3M Buy
41,779
+15,698
+60% +$13M 3.6% 13
2024
Q3
$23.1M Buy
26,081
+20,344
+355% +$18.3M 2.63% 18
2024
Q2
$5.19M Buy
5,737
+406
+8% +$325K 0.57% 24
2024
Q1
$4.15M Buy
5,331
+276
+5% +$196K 0.49% 26
2023
Q4
$2.95M Buy
5,055
+143
+3% +$83.5K 0.39% 27
2023
Q3
$2.64M Sell
4,912
-494
-9% -$255K 0.4% 26
2023
Q2
$2.54M Buy
5,406
+671
+14% +$281K 0.38% 28
2023
Q1
$1.63M Buy
4,735
+175
+4% +$59K 0.27% 27
2022
Q4
$1.67M Buy
4,560
+345
+8% +$122K 0.31% 25
2022
Q3
$1.36M Sell
4,215
-1,730
-29% -$548K 0.27% 26
2022
Q2
$1.93M Buy
5,945
+740
+14% +$222K 0.34% 24
2022
Q1
$1.49M Buy
5,205
+290
+6% +$74.6K 0.22% 25
2021
Q4
$1.36M Buy
4,915
+25
+0.5% +$6.34K 0.17% 25
2021
Q3
$1.13M Sell
4,890
-1,430
-23% -$353K 0.16% 25
2021
Q2
$1.45M Buy
6,320
+230
+4% +$46.2K 0.19% 23
2021
Q1
$1.14M Buy
6,090
+175
+3% +$34.2K 0.17% 23
2020
Q4
$999K Buy
5,915
+1,200
+25% +$179K 0.16% 24
2020
Q3
$698K Buy
4,715
+755
+19% +$117K 0.12% 25
2020
Q2
$650K Buy
+3,960
New +$608K 0.12% 25

Other funds holding LLY

Suncoast Equity Management's LLY Position: Q1 2026 in Review

Suncoast Equity Management reduced its Eli Lilly (LLY) stake by 8.8% in Q1 2026, selling an estimated $3.81M and leaving 38,951 shares worth $35.8M. The position accounts for 4.3% of the portfolio, ranked #9.

Suncoast Equity Management first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $45.9M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Suncoast Equity Management held 38,951 shares of Eli Lilly worth $35.8M as of Q1 2026.
  • Suncoast Equity Management sold 3,760 Eli Lilly shares in Q1 2026, an estimated $3.81M.
  • Eli Lilly made up 4.3% of Suncoast Equity Management's portfolio in Q1 2026, its #9 holding.
  • Suncoast Equity Management first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • Suncoast Equity Management's Eli Lilly position peaked at $45.9M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Suncoast Equity Management's 13F filing for Q1 2026, filed 8 May 2026.